XYLOCAINE 5 % A LA NAPHAZOLINE, solution for application muqueuse bottle, 24 ml
Active ingredients: Lidocaine hydrochloride, Lidocaine hydrochloride, Naphazoline nitrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for applicationbottle, 24 mlauriculaire;gingivale;nasale;voie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XYLOCAINE 5 POUR CENT A LA NAPHAZOLINE, solution pour application muqueuse
- Pharmaceutical form
- solution pour application
- Route of administration
- auriculaire;gingivale;nasale;voie buccale autre
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 24 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1958
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62545178CIP73115270CIP133400931152705Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NITRATE DE NAPHAZOLINEsolution | 0,02 g · 100 ml de solution pour application muqueuse | SA |
| CHLORHYDRATE DE LIDOCAÏNEsolution | 5,332 g · 100 ml de solution pour application muqueuse | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREsolution | 5,00 g · 100 ml de solution pour application muqueuse | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.